Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Submitted by susan on Thu, 2015-08-06 14:57
A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. The researchers report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.
Main Topic:
Mark Content Private(Internal):
External URL:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961117-5/abstract
Email Alert:
1-10
Publication Date:
31/07/2015